RedHill Biopharma (Israel) Price Prediction and Hype Density Breakdown

RDHL -- Israel Stock  

ILS 312.00  2.00  0.65%

We analyze noise-free headlines and recent hype associated with RedHill Biopharma Ltd which may create opportunities for some arbitrage if properly timed. With RedHill Biopharma hype-based prediction module you can estimate the value of RedHill Biopharma Ltd from the prospective of RedHill Biopharma response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on RedHill Biopharma over a specific investment horizon. Additionally take a look at Your Equity Center.
Horizon     30 Days    Login   to change

RedHill Biopharma After-Hype Price Density Analysis

 Next price density 
      Expected price to next headline 

RedHill Biopharma Estimiated After-Hype Price Volatility

April 18, 2019
Current Value
After-hype Price
RedHill Biopharma is Unknown risk asset. Analysis and calculation of next after-hype price of RedHill Biopharma is based on 2 months time horizon.

RedHill Biopharma Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.33% 6.02% 1.65%  0.08% 6 Events / Month7 Events / MonthIn about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

RedHill Biopharma Hype Timeline

RedHill Biopharma is at this time traded for 312.00on Tel Aviv Stock Exchange of Israel. The entity has historical hype elasticity of 1.65 and average elasticity to hype of competition of -0.08. RedHill Biopharma Ltd is anticipated not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 120.4%. The immediate return on the next news is anticipated to be very small where as daily expected return is at this time at 0.33%. The volatility of relative hype elasticity to RedHill Biopharma is about 2408.0%%. The volatility of related hype on RedHill Biopharma is about 2408.0% with expected price after next announcement by competition of 311.92. The company recorded loss per share of 0.17. RedHill Biopharma had not issued any dividends in recent years. Assuming 30 trading days horizon, the next anticipated press release will be in about 6 days.
Additionally take a look at Your Equity Center.

RedHill Biopharma Related Hype Analysis

At Risk
Compugen Ltd(10.00) 3 per month 3.46  0.21  9.25 (5.64)  18.86 
Kamada Ltd 9.00 4 per month 1.22  0.12  3.12 (2.71)  7.82 
Clal Biotechnology Industries Ltd(8.20) 3 per month 2.32  0.05  3.79 (2.94)  13.31 
Pluristem Therapeutics 16.10 4 per month 0.00 (0.15)  4.62 (9.70)  51.61 
BioLine Rx Ltd(1.00) 3 per month 0.00 (0.0422)  7.02 (3.56)  40.05 
Evogene Ltd(18.30) 3 per month 2.74 (0.0067)  3.32 (4.99)  32.98 
Protalix BioTherapeutics 7.50 4 per month 3.76  0.08  9.41 (5.80)  30.22 
Can Fite BioPharma Ltd 2.40 5 per month 0.00 (0.17)  6.77 (6.59)  40.49 
Hadasit Bio Holdings Ltd 0.00 0 per month 0.00 (0.07)  3.12 (3.81)  12.94 
D N A Biomedical Solutions Ltd 0.00 0 per month 1.66  0.12  4.82 (3.54)  14.61 
Additionally take a look at Your Equity Center. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.